Breakthroughs in Prostate Cancer Treatment Offer Hope for High โCure Rates
Sherbrooke,Quebec – Patients diagnosedโ with prostate cancer now have reason for optimism,as advancements in detection โคand surgical techniquesโค at the Centre hospitalier universitaire de Sherbrooke (CHUS) are contributing to an estimated 80% cureโค rate,according to leading urologists. The โคpositive outlookโข comesโฃ as the hospital seeks to โฃexpand its technological capabilities to further improve outcomes andโ reduce patient wait times.
prostate โฃcancer remains the most commonly diagnosed cancer โคin Canadian men. Early and accurate diagnosis, coupled with increasingly elegant treatment options, areโ dramatically improving survival rates.The CHUS urology team’s success highlights the critical role of specialized care and ongoing investment in medical technology. This progress offers โrenewed โhope for the approximately 21,000 Canadianโ men diagnosed with prostate cancer each year, and underscores the importance of regular screenings andโค prompt medical attention.
Dr.Garcรญa โฃFreire, head of Urology at CHUS, revealed the scope of the department’s โwork, performing between 200 and 250 radical prostatectomies annually, alongside approximately 680 transrectal biopsies and 340 MRI-guided fusion biopsies. Theseโ fusion biopsies, utilizing advanced imaging, boast โขa detection rate of 60 to 65%.
Currently, the service provides follow-up โฃcare for 80 to 100 patientsโ eachโข week, while together treating other urologicalโ cancers, including those โคaffecting the bladder and kidneys. โ โ
Looking ahead, Dr. Garcรญa Freire emphasized the need for continued investment in technology. “Hopefully we can have โa new robot as soon as possible.โ That would allow us to โimprove results and reduce waiting times,” โฃhe stated.
